StockNews.com Initiates Coverage on China Pharma (NYSE:CPHI)

StockNews.com assumed coverage on shares of China Pharma (NYSE:CPHI) in a research note issued to investors on Tuesday. The firm set a “hold” rating on the stock.

China Pharma Trading Up 5.0 %

CPHI stock opened at $0.19 on Tuesday. China Pharma has a one year low of $0.13 and a one year high of $0.69. The company has a debt-to-equity ratio of 0.22, a quick ratio of 0.26 and a current ratio of 0.79. The firm’s fifty day moving average is $0.21 and its 200 day moving average is $0.22.

China Pharma Company Profile

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People’s Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.